ELAINE GOOLSBEY: Open Payments
NPI 1174044069 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 35 payments from 10 companies in 2025. Trend: 2023 $521 · 2024 $638 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $373 |
| Amarin Pharma, Inc. | 1 | $103 |
| Amgen Inc. | 5 | $97 |
| Abbott Laboratories | 1 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Inspire Medical Systems, Inc. | 1 | $43 |
| AtriCure, Inc. | 1 | $41 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
Products named: Ozempic, Vascepa, REPATHA, CARDIOMEMS, INSPIRE, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, VERQUVO, LEQVIO.
Industry payments across TX — which companies pay providers there.
